Testosterone boosters and heart health: what the evidence shows

Walk into any Chemist Warehouse from Parramatta to Perth and you'll find shelves stacked with bottles promising to restore youthful vigour, build lean muscle, and reignite a flagging libido. Testosterone boosters sit alongside multivitamins and protein powders, marketed to Australian men who feel their energy slipping somewhere around their fourth decade. The pitches are confident, the labels glossy, and the price tags often reach $60 to $90 for a month's supply.

Beneath the marketing muscle, a quieter conversation is unfolding in cardiology clinics and research journals. Cardiologists in Melbourne and Sydney have begun flagging patients who arrive with elevated blood pressure, irregular heartbeat, or chest discomfort, all while taking over-the-counter supplements designed to raise testosterone. Some of these products contain ingredients with documented cardiovascular effects, while others rely on compounds whose long-term impact on the heart remains poorly understood.

The tension is genuine. Testosterone does play a role in cardiovascular function, and abnormally low levels can themselves contribute to heart problems. Yet boosting the hormone artificially, particularly through unregulated supplements, introduces a different set of risks that mainstream research is only beginning to map with clarity. Studies published in major medical journals have produced conflicting headlines, leaving consumers caught between aggressive advertising and cautious science.

This piece examines what peer-reviewed evidence actually says about the relationship between testosterone-boosting supplements and heart health. It looks at the ingredients most commonly linked to cardiac concerns, the way Australian regulators classify these products, and what practical choices men can make when weighing potential benefits against documented risks.

How testosterone boosters are sold across Australia

In Australia, testosterone boosters are regulated as complementary medicines by the Therapeutic Goods Administration, which means they can be listed rather than fully evaluated for efficacy before reaching pharmacy shelves. Walk into a Priceline in Brisbane's CBD or a TerryWhite Chemmart in Adelaide, and you'll see products bearing "AUST L" numbers that signal compliance with safety standards but say little about whether the formula actually raises testosterone in the human body.

The marketing leans heavily on athletic identity. Labels reference gym culture, body composition, and "peak male performance", often accompanied by imagery borrowed from professional sport. Some brands sponsor local fitness influencers, while others advertise during rugby league coverage on Channel Nine. The implied audience is the everyday Aussie bloke who wants to keep up with his mates at the local footy match or hold his own in a CrossFit box in the inner suburbs.

Price points vary widely. A 60-capsule bottle might cost $45 at one retailer and $75 at another, with no obvious difference in ingredient quality. Subscription models offered through online Australian retailers add another layer of convenience, though they also make it easier to continue taking a product long after any short-term trial period has ended. The result is a market where consumers often commit to months of supplementation without medical supervision.

Cardiologists interviewed in Australian medical press have noted that many patients do not mention their supplements during routine consultations, either because they consider them natural and therefore harmless, or because the conversation simply never comes up. This communication gap is part of why the cardiovascular effects of these products have slipped under the radar for so long.

The heart and hormones: a delicate balance

Testosterone interacts with the cardiovascular system in ways that researchers are still untangling. The hormone influences red blood cell production, vascular tone, lipid metabolism, and inflammatory pathways. Healthy physiological levels support normal cardiac function, but both deficiency and excess can stress the heart in different ways.

When testosterone rises too high, the body often responds by producing more red blood cells, thickening the blood and increasing the risk of clot formation. Elevated haematocrit is a well-known marker for thrombotic events, including deep vein thrombosis and pulmonary embolism. Blood pressure can climb as vascular resistance increases, and changes in cholesterol profiles may tip toward patterns associated with atherosclerosis over time.

For men with pre-existing conditions such as hypertension, atrial fibrillation, or coronary artery disease, these physiological shifts can be particularly dangerous. General practitioners in regional Queensland and Tasmania have reported seeing patients on testosterone-supporting supplements who present with poorly controlled blood pressure despite being on antihypertensive medication. Discontinuing the supplement sometimes brings readings back to baseline within weeks.

The challenge is that symptoms often build slowly. A man might notice improved gym performance, better recovery, and a renewed sense of drive long before any cardiovascular warning signs appear. By the time a cardiologist identifies the problem, the patient may have been self-medicating for months or years, often with multiple products stacked together.

What clinical studies have found

The scientific literature on testosterone boosters and heart health is mixed, partly because the studies cover different populations, formulations, and durations. A landmark 2010 trial known as the TOM study was halted early after researchers observed a higher rate of cardiovascular events in men given testosterone gel compared to placebo. Subsequent meta-analyses have produced conflicting results, with some suggesting increased risk of heart attack and stroke, and others finding no significant difference.

The discrepancy comes down to study design. Trials that include men with pre-existing heart disease tend to show harm, while studies of healthier younger populations often show neutral or mildly positive outcomes. Age, baseline testosterone, dosage, and route of administration all appear to influence the cardiovascular picture. Oral testosterone formulations, for example, have been linked to liver toxicity and lipid disturbances, whereas transdermal options carry different risk profiles.

Over-the-counter supplements complicate the picture further. Unlike prescription testosterone, these products typically contain herbal extracts, minerals, and amino acids such as tribulus terrestris, fenugreek, zinc, and D-aspartic acid. Few of these ingredients have been studied in large, long-term trials, and even fewer have been evaluated specifically for cardiovascular safety in combination with one another.

Researchers at the University of Western Australia and the Baker Heart and Diabetes Institute in Melbourne have called for more rigorous Australian-specific studies, noting that the genetic backgrounds, lifestyle patterns, and supplement habits of local men may differ from those in the predominantly American and European trial populations. Until such data emerges, the existing evidence can be interpreted in many ways, often to suit the marketing narrative a particular brand wants to tell.

Ingredients worth a closer look

Several ingredients appear repeatedly in Australian-market testosterone boosters, and a handful of these have raised cardiovascular red flags in published research.

Common compounds and their documented concerns:

• Tribulus terrestris: Limited evidence for actual testosterone elevation; rare case reports of kidney and liver stress
• Fenugreek: May interact with blood-thinning medications and affect blood sugar regulation
• Yohimbine: Documented increases in heart rate and blood pressure; not recommended for those with anxiety or cardiac conditions
• High-dose zinc: Long-term excess linked to copper depletion and potential cardiac implications

Another concern is stacking. Many Australian men combine a testosterone booster with pre-workout formulas, protein powders, and fat burners, often without realising that overlapping stimulants can compound cardiovascular strain. A typical stack might include caffeine, yohimbine, and synephrine, all of which raise heart rate and blood pressure independently. The cumulative effect has not been studied in controlled trials, leaving consumers to act as their own unwitting test subjects.

For those interested in exploring adaptogenic options with a more established safety profile, resources like Ashwagandha for stress, dosage, and real results offer a starting point for understanding how certain botanicals interact with hormonal and cardiovascular pathways.

Navigating the Australian supplement market

The Therapeutic Goods Administration classifies most testosterone boosters as AUST L listed medicines, which means manufacturers self-certify that ingredients are safe and manufacturing meets quality standards. The TGA does not independently verify that the product actually raises testosterone levels, only that the listed ingredients are known and the dosage falls within accepted bounds.

For consumers, this regulatory framework creates a peculiar situation. A bottle bought at a suburban pharmacy in Geelong or a health food store in Hobart carries the same official imprimatur as a prescription medicine, yet has undergone a fraction of the scrutiny. Advertising standards managed by the Therapeutic Goods Advertising Code add some protection against outlandish claims, but enforcement is reactive rather than proactive, and many questionable products remain on shelves for months before any review.

Signals worth watching for when comparing products:

• Transparent ingredient lists with exact dosages, not just proprietary blends hiding amounts
• Third-party testing certification from bodies such as Informed Sport or NSF
• Clear contact details for the Australian distributor and a local return address
• Absence of guaranteed results language in marketing materials

For ongoing coverage of supplement research, regulatory updates, and ingredient analysis tailored to Australian consumers, the editorial team at Ask24x7 regularly publishes reviews and guides that cut through the noise of wellness marketing.

When supplements warrant a medical conversation

Men considering testosterone supplementation should first request a blood test through their GP to establish baseline levels. Medicare covers pathology testing when ordered by a physician, and the results provide a far more reliable starting point than any marketing claim. If levels are genuinely low, a conversation about prescription options, lifestyle changes, and evidence-based supplementation can follow, ideally with a practitioner who understands both endocrinology and cardiology.

Red flags that should prompt an immediate medical review include chest discomfort during exercise, unexplained shortness of breath, palpitations that persist after rest, and blood pressure readings consistently above 140 over 90. These symptoms can indicate underlying cardiovascular strain that a supplement may be worsening, and they warrant professional investigation rather than a wait-and-see approach.

Lifestyle factors often deliver more reliable benefits than any pill. Resistance training has been shown in Australian studies to support healthy testosterone levels in men over 40, while adequate sleep, weight management, and reduced alcohol intake all contribute to hormonal balance. Stress management matters too, since chronically elevated cortisol suppresses testosterone production through well-documented endocrine pathways.

The honest summary is that testosterone boosters occupy a regulatory grey zone, an evidence base still under construction, and a commercial environment that prioritises sales over subtlety. Australian men deserve clearer information, and the most reliable path forward remains a conversation with a trusted GP, supported by bloodwork and an honest appraisal of what supplements can and cannot do.